Clinical Status: 5-Amino-1MQ is a research compound evaluated in preclinical and emerging human studies for obesity, insulin resistance, and metabolic health applications
PMID 28405070
These modifications are also believed to assist at least 90% of the peptide to bind covalently to blood albumin, with trace amounts potentially binding to fibrinogen and immunoglobulin G (IgG)
These types of products could have naturally derived peptides or synthetic peptides
These are MHRA-licensed medicines a very different category from unregulated food supplements
A., Rmer, J., Ahnfelt-Rnne, I., Ohlsson, C., & Jansson, J